Resuming post living donor liver transplantation in the COVID-19 pandemic: real-life experience, single-center experience

Egyptian Liver Journal

Table 3 Laboratory findings of the third patient

Date	Day 1 post-transplant	On discharge	Normal value
TLC	9.5	3.2	4-11 × 10³/cmm
Lymphocyte	11	11.9	20–45
Hb	9	9.5	12–15 g/dl
PLT	87	59	150–450 × 10⁹/L
CRP	10.8	4.8	Up to 5 mg/l
Urea	56	48	7–50 g/dl
Creatinine	0.6	0.6	0.60–1.30 mg/dl
Na	136	136	136–145 mmol/l
K	4.4	4.2	3.5–5.1 mmol/l
AST	266	40	Up to 32 u/l
ALT	197	203	Up to 35 u/l
Albumin	3.2	3.5	3.5–5.2 g/dl
T. Bilirubin	13.4	7	0.3–1.2 mg/dl
D. Bilirubin	6.6	4.4	0.1–0.3 mg/dl
GGT	31	341	Up to 35 u/l
ALP	836	216	30–120 u/l
PC%	29	71	100%
INR	2.6	1.26	1

TLC total leucocytic count, Hb hemoglobin, PLT platelet count, CRP C-reactive protein, Na sodium, K potassium, AST aspartate transaminase, ALT alanine transaminase, T. Bilirubin total bilirubin, D. Bilirubin direct bilirubin, GGT gamma-glutamyl transferase, ALP alkaline phosphatase, PC% prothrombin concentration, INR international normalized ratio